Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

BioNexus Gene Lab Corp. (BGLC)

NASDAQ

$1.52

$+0.08

(+5.91%)

Pre-Market

BioNexus Gene Lab Corp. (BGLC) Live Price Chart

Last updated: ⁦2026-09-16 12:10:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

BioNexus Gene Lab Corp. (BGLC) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $1.52, with a market capitalisation of $4.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $6.10. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.40M
Open	$1.44
Day's High	$267.60
Day's Low	$1.07
Previous Close	$1.44
Volume	250.00
Average Volume	16.83K
P/E Ratio	--
52-Week High	$6.10
52-Week Low	$1.07
Dividend Yield	--
Earnings Date	--

BioNexus Gene Lab Corp. (BGLC) Pre-Market Stock Price

BioNexus Gene Lab Corp. (BGLC) is trading at $1.52 in pre-market trading as of 2026-09-16 12:08:00, up 5.76% ($0.08) from the previous close of $1.44

Pre-market trading shows how investors are pricing BGLC before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

BioNexus Gene Lab Corp. (BGLC) 7-Day Stock Price Change

Over the past seven days, BioNexus Gene Lab Corp. (BGLC) moved from $1.45 to $1.52, representing a gain of 5.03% ($0.07).

The stock traded between $1.34 and $1.61 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 4.29 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BGLC 52-Week Price Position

Position in Range: 9.0%

52W Low$1.07

52W High$6.10

BGLC is currently trading at $1.52, placing it 9.0% of the way from its 52-week low of $1.07 to its 52-week high of $6.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BioNexus Gene Lab Corp. (BGLC)?

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

BioNexus Gene Lab Corp. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	1
Exchange	NASDAQ
Company Website	https://www.bionexusgenelab.com

How to Buy BioNexus Gene Lab Corp. (BGLC) Stock on MEXC

Eligible investors can buy real shares of BioNexus Gene Lab Corp. (BGLC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BGLC and Place Your Order

Open the RealStocks trading page and search for BGLC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BioNexus Gene Lab Corp. (BGLC) stock price today?

BioNexus Gene Lab Corp. (BGLC) is currently trading at $ 1.52, up 5.76% ($0.08) from the previous close of $ 1.44. Intraday prices update in real time during regular trading hours.

2.Is BGLC stock going up or down today?

As of 2026-09-16 12:08:00, BGLC is trading at $ 1.52, up 5.76% ($0.08) from its previous close of $ 1.44. The stock has traded between $ 1.07 and $ 267.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is BGLC pre-market price?

As of 2026-09-16 12:08:00, BGLC is trading at $ 1.52 in pre-market trading, up 5.76% ($0.08) from the previous close of $ 1.44. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BGLC after-hours price?

As of 2026-09-16 12:08:00, BGLC is trading at $ 1.43 in after-hours trading, down 0.76% ($0.01) from the regular-session close of $ 1.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BGLC stock trading now?

BGLC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BGLC sit relative to its 52-week high and low?

Over the past 52 weeks, BGLC has traded between a low of $ 1.07 and a high of $ 6.10. At $ 1.52, the stock is positioned 9.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BioNexus Gene Lab Corp. in?

BioNexus Gene Lab Corp. (BGLC) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BioNexus Gene Lab Corp.'s market capitalisation and where is it listed?

BioNexus Gene Lab Corp. is listed on the NASDAQ exchange with a market capitalisation of $ 4.40M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BGLC valued in terms of P/E ratio and EPS?

BGLC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.88. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BioNexus Gene Lab Corp. pay a dividend?

BioNexus Gene Lab Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.